Shandon Clinic was initially founded as a bioequivalence unit catering to the generics industry. The resources within the clinic are set up to provide our clients with a full service, from initial study design through to final integrated study report.
Shandon Clinic’s key strengths in bioequivalence testing include:
We have an extremely high rate of repeat business, with clients saying that they particularly value the rapid responsiveness of senior staff at Shandon Clinic and the ‘hands-on’ management of their projects by experienced researchers.
Shandon Clinic has recently expanded: Clinical units in South Africa and Turkey now afford us increased capacity and allow provision of cost-effective service to clients who have difficulty meeting the requirements imposed by the EU Clinical Trials Directive.